The following information was copied from the US
Army Medical Materiel Command's information release about the new CLS
bag. For the actual "new" CLS bag inventory listing,click here.
For the "old" (traditional) CLS bag inventory,
click here.
"As a result of new advances in trauma
management and feedback from users in
the field, the Army has updated the combat lifesaver (CLS) bag. The new
CLS bag
combines treatment recommendations from the Tactical Combat Casualty
Care (TC3)
panel as well as changes in the program of instruction for CLS
providers. Due to the
number and type of changes made to the components, the CLS bag now has a
new NSN
(National Stock Number), 6545-01-532-3674 and a new unit assemblage
number, 1245.
The Common Table of Allowances (CTA) is updated to reflect these
numerical changes.
The long nomenclature of this CLS bag is listed as “MES Combat Lifesaver
version
2005” to avoid confusion with the previous version, and is populated in
the medical
databases of Medical Services Information Logistics Systems (MEDSILS)
and the Unit
Data Repository (UDR).
Components of the new MES, with their corresponding NSN and quantity,
are
provided in the table below. It is important to note that although a
Chitosan bandage is
being authorized for inclusion in the Southwest Asia theater, it is NOT
currently a
component of the assemblage. Also, while the Medical Chemical Defense
Materiel items
of Atropine and Diazepam remain authorized in the UA and therefore
listed, the
assemblage will be fielded without those two items. This is to comply
with the currently
established centralized process for ordering these items. The new
components, for ease of
identification, are also listed in the “characteristics” field of
MEDSILS and the UDR
under the above NSN. Due to cost issues, the proposed bag in the
assemblage 6545-01-537-0686, BAG, TC3, COMBAT CASUALTY CARE will not be fielded with the
assemblage. The components will continue to be issued in the old bag,
6545-00-912-9870, CASE #3 10X4-1/2X18IN.
Hextend will remain a component of the CLS assemblage. This policy has
been
coordinated with the Office of the Surgeon General. That does not, of
course, negate the
unit surgeon’s authority to replace that fluid with a crystalloid as he
deems necessary
with regard to his/her CLS providers and the mission. USAMMA/DSCP will
not build
multiple CLS assemblages with different intravenous fluids. That
substitution can be
done at the local level. As of now, 03 April 2006, DSCP is filling
orders for the CLS bag
with the new components.
Information regarding the updates to the
CLS bag will be communicated to the
field in the following ways: via the USAMMA website and in the
appropriate supply
bulletin (SB). USAMMA will also try to disseminate via the AMEDDC&S
website,
appropriate email lists for division/brigade/battalion surgeons, TRADOC,
and the AKO
homepage. Questions regarding these changes may be directed to USAMMA,
(301) 619-4305 (DSN 343-4305).